Nonmedical prescriber experiences of training and competence to report adverse drug reactions in the UK.
adverse drug reactions
patient safety
pharmacovigilance
Journal
Journal of clinical pharmacy and therapeutics
ISSN: 1365-2710
Titre abrégé: J Clin Pharm Ther
Pays: England
ID NLM: 8704308
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
06
06
2018
revised:
17
07
2018
accepted:
26
07
2018
pubmed:
13
9
2018
medline:
14
3
2019
entrez:
13
9
2018
Statut:
ppublish
Résumé
Adverse drug reaction reporting in the UK is lower than expected based on epidemiological data. This study aims to explore (a) nonmedical prescribers' (NMP) confidence in identifying and reporting ADRs, (b) NMP prescribing habits and engagement with the Yellow Card Scheme (YCS) and (c) NMP desire for future training in the identification and reporting of ADRs. A survey was distributed across NMP networks in the north-west of England using Survey Monkey. Univariate analyses were performed to compare the features of reporters and nonreporters, Kruskal-Wallis H tests for comparisons within multiple subgroups and Spearman's rank correlation coefficient for response associations between answers to ordered-category questions. A total of 570 responses were available for analysis, an estimated response rate of 20%. Less than half (n = 219; 38.4%) reported submitting a Yellow Card to the YCS, and the majority of those individuals have submitted five or less Yellow Cards; 28 responders reported more than five submissions. Being professionally qualified for more years (linear regression: B = 0.30, P < 0.0005; 95% CI 1.01 to 1.05) and receiving additional training support about the YCS (chi-squared: χ Strategies for improving the translation of theoretical knowledge about ADRs into practical skills in identifying ADRs, and subsequently reporting them, will be important for improving pharmacovigilance practice.
Identifiants
pubmed: 30206951
doi: 10.1111/jcpt.12756
pmc: PMC6378616
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
78-83Subventions
Organisme : Medical Research Council
ID : MR/L006758/1
Pays : United Kingdom
Organisme : National Institute for Health Research
Informations de copyright
© 2018 The Authors. Journal of Clinical Pharmacy and Therapeutics Published by John Wiley & Sons Ltd.
Références
Br J Clin Pharmacol. 2011 Jul;72(1):143-52
pubmed: 21332572
J Clin Epidemiol. 2002 Sep;55(9):945-50
pubmed: 12393084
Drug Saf. 2006;29(5):385-96
pubmed: 16689555
Br J Clin Pharmacol. 2001 Jan;51(1):81-6
pubmed: 11167664
BMJ. 2004 Jul 3;329(7456):15-9
pubmed: 15231615
J Clin Pharm Ther. 2019 Feb;44(1):78-83
pubmed: 30206951
Int J Clin Pharm. 2013 Apr;35(2):268-74
pubmed: 23277419
Saudi Pharm J. 2014 Apr;22(2):83-94
pubmed: 24648818
Curr Med Chem. 2010;17(6):571-84
pubmed: 20015034
Drug Saf. 2000 Aug;23(2):165-72
pubmed: 10945377
Ir J Med Sci. 1999 Oct-Dec;168(4):257-61
pubmed: 10624366
Drug Saf. 2005;28(9):825-33
pubmed: 16119975
Trends Pharmacol Sci. 2017 Jan;38(1):100-109
pubmed: 27955861
Drug Saf. 2009;32(1):19-31
pubmed: 19132802
Br J Clin Pharmacol. 1995 Mar;39(3):223-6
pubmed: 7619660
Eur J Clin Pharmacol. 1997;52(6):423-7
pubmed: 9342576